Phase 1 Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 years or older
- People with known or suspected breast cancer, whether it started in the breast or has spread to other parts of the body
- People who have at least one breast cancer lesion (area of concern) measuring 1.0 cm or larger that has already shown up on a standard scan such as a CT, MRI, mammogram, ultrasound, or PET/CT scan
- People who are willing to be informed about the research nature of this study and sign a written consent form before any study procedures begin
Who may not be able to join:
- People who are pregnant or breastfeeding at the time of screening (a urine pregnancy test will be carried out for women who could potentially become pregnant)
- People who, in the opinion of the investigating or treating doctor, would not be able to tolerate the imaging procedures involved in the study
- People who have a current medical condition, illness, or disorder that a doctor considers could affect their safety or ability to fully participate in the study (this may be identified through medical records or self-reporting)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Austin Pantel, MD, Instructor of Radiology
Phone: 215-573-6569
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Kinetics and Biodistribution of [18F]F-GLN
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.